Skip to main content
. 2020 Dec 30;15(12):e0244558. doi: 10.1371/journal.pone.0244558

Fig 8. Overall survival (months) between DACH1 mutated patients versus wild-type.

Fig 8

(A). Overall survival (months) between DACH1 mutated patients and wild-type at MCC, corrected for stage and grade, were found to be similar withno significant difference (p-value = 0.803) though limited outcome data in DACH1 mutated patients. (B). Overall survival (months) between DACH1 mutated patients and wild-type was also evaluated in the TCGA PCA (p-value = 0.196) patients with no significant difference.